Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Weissert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Urology|June 13, 2019
American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation-Should Patient Age be Added to the Risk Model?Kourosh Ravvaz, John A Weissert, Tracy M Downs
Plos One|March 18, 2021
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationKourosh Ravvaz, John A Weissert, Arshad Jahangir, et al.
The Journal of Urology|April 24, 2017
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in a United States PopulationKourosh Ravvaz, Marcus E Walz, John A Weissert, et al.
Urologic Oncology|May 31, 2021
Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopyRichard S Matulewicz, Kourosh Ravvaz, John A Weissert, et al.
Circulation. Cardiovascular Genetics|December 15, 2017
Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical TrialsKourosh Ravvaz, John A Weissert, Christian T Ruff, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Urology|June 13, 2019
American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation-Should Patient Age be Added to the Risk Model?Kourosh Ravvaz, John A Weissert, Tracy M Downs
Plos One|March 18, 2021
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationKourosh Ravvaz, John A Weissert, Arshad Jahangir, et al.
The Journal of Urology|April 24, 2017
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in a United States PopulationKourosh Ravvaz, Marcus E Walz, John A Weissert, et al.
Urologic Oncology|May 31, 2021
Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopyRichard S Matulewicz, Kourosh Ravvaz, John A Weissert, et al.
Circulation. Cardiovascular Genetics|December 15, 2017
Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical TrialsKourosh Ravvaz, John A Weissert, Christian T Ruff, et al.
Pageof 1